Immunis, Inc.
Clinical trials sponsored by Immunis, Inc., explained in plain language.
-
Special access opens for patients with muscle loss and obesity
Disease control TEMPORARILY_NOT_AVAILABLEThis program provides access to an experimental treatment for people with sarcopenic obesity (low muscle mass combined with excess body fat) who cannot participate in regular clinical trials. It's designed for patients who meet specific criteria for both obesity and muscle weakne…
Sponsor: Immunis, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Could stem cell 'Juice' reverse Age-Related muscle loss?
Disease control OngoingThis study is testing whether injections of secretions from special cells can safely improve muscle strength and body composition in adults aged 60-80 who have both obesity and muscle weakness. Participants receive injections twice a week for four weeks and are monitored for safe…
Phase: PHASE2 • Sponsor: Immunis, Inc. • Aim: Disease control
Last updated Mar 10, 2026 12:53 UTC